A DNA synthesis company using a next-generation silicon-based technology platform.
On May 27 2014, Twist Bioscience completed a $26,000,000 series B funding roundfunding round. Investors include: DARPA, ARCH Venture Partners, Paladin Capital Group, Yuri Milner, and some undisclosed investors.
Twist Bioscience and Synbio Technologies became partners on July 11th, 2017. The partnership seeks to combine technologies being used at both companies, by offering DNA strands up to 70 kilobases in length. Twist Bioscience will synthesize DNA strands up to 3.2 kilobases in length before shipping them off to Synbio Technologies for completion. This partnership gives both companies more international presence: Twist Bioscience in located in San Francisco, and Synbio Technologies is in ChinaChina, so by working together they plan to be able to offer improved DNA strand products that enhance scientific research for the diagnosis and treatment of disease.
February 25, 2020